About
Marina Pellón-Consunji joined Ampersand in 2013. She previously worked as an Associate Director in Healthcare Investment Banking at UBS, handling leveraged buyouts, M&A, and debt and equity financings for middle-market healthcare companies. She holds a B.A. with Honors in Biological Chemistry and International Relations from Wellesley College and worked in biochemistry laboratories at Harvard Medical School after graduating.
Invests in
BiotechHealthtech
Investments
Board seats
GeneWerkGyros PTIProtageneVibalogicsVivebiotech
Per the firm's website.
Colleagues at Ampersand
Aditya V. Goel
Associate at Ampersand
Benoit P. Bouche
Operating Partner at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
David Q. Anderson
General Partner at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand
Frequently asked questions
- Who is Marina Pellón-Consunji?
- Marina Pellón-Consunji joined Ampersand in 2013. She previously worked as an Associate Director in Healthcare Investment Banking at UBS, handling leveraged buyouts, M&A, and debt and equity financings for middle-market healthcare companies. She holds a B.A. with Honors in Biological Chemistry and International Relations from Wellesley College and worked in biochemistry laboratories at Harvard Medical School after graduating.
- Where does Marina Pellón-Consunji work?
- Marina Pellón-Consunji is Partner at Ampersand.
- What does Marina Pellón-Consunji invest in?
- Marina Pellón-Consunji invests in Biotech, Healthtech.
- What boards does Marina Pellón-Consunji sit on?
- Marina Pellón-Consunji holds tracked board seats at GeneWerk, Gyros PTI, Protagene, Vibalogics, Vivebiotech.